Brind.
  1. Filing requirements governing market operations are in effect, involving Nasdaq and the SEC.
  2. United Therapeutics filed required documents for executive stock transactions and listed its stock on the exchange.

United Therapeutics disclosed stock sales by CEO Martine Rothblatt via required SEC filing.

2 reports, 1 independent Updated Jul 13
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

United Therapeutics disclosed stock sales by CEO Martine Rothblatt via required SEC filing.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
1 more outlet ran the same wire story